Eli Lilly’s Alzheimer’s drug wins FDA approval

Date:

July 2, 2024

An Eli Lilly & Co. Alzheimer’s drug won Food and Drug Administration approval Tuesday, capping the medication’s bumpy ride through the U.S. regulatory process and adding a second new treatment option for patients in earlier stages of the disease.

Source link

AI is learning from what you said on Reddit, Stack Overflow or Facebook. Are you OK with that?

Alabama football lands 4-star tight end Kaleb Edwards: What it means for Tide

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Eli Lilly’s Alzheimer’s drug wins FDA approval

Recent posts

Who is Salim Ramji, the new Vanguard CEO?

IEA lowers 2024 oil-demand forecast

Amid ‘Ozempic babies’ questions, women account for more than 75% of young adults taking GLP-1 drugs, study finds

Why stock-market gains seen after April’s PCE inflation report faded so fast

A ‘pick and mix’ stock market has emerged thanks to higher interest rates, says Goldman Sachs

Chevron stock pulls back as profit drops, amid a plunge in natural-gas prices

Larry Summers says the Fed and investors are ‘badly wrong’ on inflation’s path

Fidelity’s new service charge poses ‘existential’ threat to some ETFs

AMC’s theaters have their best weekend of 2024 thanks to ‘Inside Out 2’ — but its stock is falling

Uranium ETF soars to 10-year high on rising demand and Russia import ban

Democratic congressman warns crypto may become winning issue for GOP after Trump voices support

Interactive Brokers accepts $48 million loss tied to NYSE glitch

U.S. trade deficit widens for third straight month in February

Why coffee futures may have already hit their peak for the year

Bed Bath & Beyond’s new parent company says it’s still working on winning back repeat customers

Related articles

This week’s U.S. inflation report could have serious implications for stocks

U.S. presidential election highlights biggest risk to a bond-market rally in the second half

Natural-gas prices dropped 11% this week. Beryl may fuel further losses.

Oil prices on track for 4th straight weekly gain

Arkhouse, Brigade reportedly try to sweeten offer to buy Macy’s

Gold prices look to settle at 1-month high as silver jumps nearly 4%

JPMorgan’s top strategist Marko Kolanovic is leaving after missing stocks’ historic rally

Hurricane Beryl puts focus on oil with climate change likely to intensify storms

Company

Follow us